BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25025441)

  • 21. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases.
    Pan X; Zhang M; Yao J; Zeng H; Nie L; Gong J; Chen X; Xu M; Zhou Q; Chen N
    J Clin Pathol; 2019 Nov; 72(11):748-754. PubMed ID: 31262952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
    Ricketts CJ; Shuch B; Vocke CD; Metwalli AR; Bratslavsky G; Middelton L; Yang Y; Wei MH; Pautler SE; Peterson J; Stolle CA; Zbar B; Merino MJ; Schmidt LS; Pinto PA; Srinivasan R; Pacak K; Linehan WM
    J Urol; 2012 Dec; 188(6):2063-71. PubMed ID: 23083876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
    Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
    Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.
    CaliĆ³ A; Grignon DJ; Stohr BA; Williamson SR; Eble JN; Cheng L
    Mod Pathol; 2017 Mar; 30(3):407-415. PubMed ID: 27910947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
    Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
    Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
    He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O
    Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; CompƩrat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
    Mason EF; Hornick JL
    Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
    Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
    Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Succinate dehydrogenase (SDH)-deficient neoplasia.
    Gill AJ
    Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Succinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer.
    Kodare D; Menon S; Prakash G; Desai S
    Indian J Cancer; 2023 Oct; 60(4):583-585. PubMed ID: 38189645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
    Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
    Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Succinate Dehydrogenase Deficient Renal Cell Carcinoma With Sarcomatoid and Rhabdoid Features-A Diagnostic Dilemma.
    Ajmal N; Lallas CD; McCue P; Li L
    Int J Surg Pathol; 2024 Feb; ():10668969241229333. PubMed ID: 38311902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
    Park S; Kang SY; Kwon GY; Kwon JE; Kim SK; Kim JY; Kim CH; Kim HJ; Moon KC; Pyo JY; Park WY; Park ES; Sung JY; Sung SH; Oh YH; Lee SE; Lee W; Lee JI; Cho NH; Jung SJ; Cho MS; Cho YM; Cho HY; Cha EJ; Chae YS; Choe G; Choi YJ; Huh J; Ro JY
    Arch Pathol Lab Med; 2017 May; 141(5):671-677. PubMed ID: 27819762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
    Miettinen M; Killian JK; Wang ZF; Lasota J; Lau C; Jones L; Walker R; Pineda M; Zhu YJ; Kim SY; Helman L; Meltzer P
    Am J Surg Pathol; 2013 Feb; 37(2):234-40. PubMed ID: 23282968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms.
    Kuroda N; Tsutsui M; Iguchi M; Nobuoka E; Uehara T; Sonobe Y; Morinaga Y; Shibuya S; Oda W; Yanai H; Kawada C; Karashima T; Yamasaki I; Inoue K; Nagashima Y
    Ann Diagn Pathol; 2020 Dec; 49():151599. PubMed ID: 32977234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.